SHADAN MARTHA 4

What Happened
Martha Shadan, a director of LeMaitre Vascular, received 476 shares of LMAT common stock on February 26, 2026 upon settlement of a Performance Share Unit (PSU) award. The reported transactions show 476 shares acquired at $0.00 (award settlement) and two small derivative conversions (one share acquired at $0.00 and one derivative share disposed at $0.00).

Key Details

• Transaction date: February 26, 2026; Form 4 filed March 2, 2026 (timely filing).
• Reported items: 476 shares acquired (code A — award/settlement); exercise/conversion entries (code M) showing 1 share acquired and 1 share disposed (both $0.00). Total cash value reported for these transactions: $0.
• Shares owned after transaction: not disclosed in the filing.
• Footnotes: F1 — 476 shares came from a PSU grant made Dec 6, 2024; 1/3 vested upon satisfaction of the performance condition on 2/26/2026, remaining shares vest in equal annual installments on the grant anniversary over the next two years. F2/F3 — dividend equivalent rights were released on a one-for-one basis and converted into shares; each dividend equivalent equals one share.
• No 10b5-1 plan, tax withholding, or other special plan direction is stated in the filing.

Context
This was an award settlement tied to performance-based PSUs, a routine form of equity compensation for insiders rather than an open-market buy or sell. The small exercise/conversion/disposition entries reflect derivative settlement activity reported on the form; the filing does not explain the reason for the one-share disposition (filings sometimes show small disposals for tax withholding but no such note is provided here). Awards being received are informative about compensation but are not a direct market purchase signal.